CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

NCT03712956 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Caelyx®

Sponsor

European Institute of Oncology

Collaborators

[object Object]